NetworkNewsBreaks Archive - Page 2117 of 2158

MondayJan 23, 2017 12:52 pm

NetworkNewsBreaks – Resonant, Inc. (NASDAQ: RESN) Aims to Change Mobile Industry with Proprietary RF Filter Design

The mobile industry is still using radio frequency filters designed based on technology that has hardly changed over the past century and therefore is not able to fully meet the industry’s new challenges and requirements. Resonant, Inc. (NASDAQ: RESN), a developer of software tools and designs for radio frequency front-ends (RFFE) filters, is looking to change that via its proprietary Infinite Synthesized Networks™ technology. ISN™ has the potential of answering one of the industry’s biggest challenges: being able to tune or reconfigure RF filters to work across several bands simultaneously. Resonant is working on developing innovative single-band and tunable designs…

MondayJan 23, 2017 12:49 pm

NetworkNewsBreaks – Digital Ally, Inc. (NASDAQ: DGLY) Capitalizing on the Increased Use of Mobile Devices

With the rampant application and use of mobile technologies, Digital Ally, Inc. (NASDAQ: DGLY) has designed a complete evidence management solution for law enforcement and security agencies, accessible through a mobile application called VuVault Go™. The app gives law enforcement officers full control of evidence, as well as the ability to take notes and playback videos. As a result, agencies have control over digital evidence while on the job. CJIS-compliant, VuVault Go™ offers secure access to recordings on both Android and iOS devices. The mobile application is part of the company’s VuVault® platform, which also includes VuVault.Com™, a secure Internet-based…

FridayJan 20, 2017 1:26 pm

NetworkNewsBreaks – Concert Pharmaceuticals’ (NASDAQ: CNCE) CTP-656 Obtains Orphan Drug Designation from FDA

Concert Pharmaceuticals (NASDAQ: CNCE) this morning reported that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for CTP-656, a next generation CFTR potentiator for the treatment of cystic fibrosis. The designation provides incentives such as tax credits related to clinical trial expenses, an exemption from the FDA user fee, FDA assistance in clinical trial design, and potential market exclusivity for seven years following approval. In December 2016, Concert initiated a phase 2 trial in the U.S. evaluating CTP-656 in cystic fibrosis patients with gating mutations. Topline data from the ongoing phase 2 trial is expected by…

FridayJan 20, 2017 12:36 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on January 20, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: MTP 11.60% – News: Provides trading update GRWG 8.84% – News: Las Vegas store officially opens MTNB 5.00% – News: Raises $13.5M from exercise of warrants BSGM 3.77% – News: Issues shareholder letter CRTN 3.64% – News: Reports persistent growth in network transformation FH 3.37% – News: To ring the Nasdaq opening bell January 23 to celebrate closing of XpresSpa acquisition FNMA 2.38% – News: Chief economist comments on 2017 outlook BLDP 2.25% –…

FridayJan 20, 2017 12:34 pm

NetworkNewsBreaks – Second Sight Medical Products, Inc. (NASDAQ: EYES) Sees Mounting Potential for Argus® II “Bionic Eye” Implants

Second Sight Medical Products (NASDAQ: EYES) develops, manufactures and markets implantable prosthetic devices to restore functional vision to blind patients. The company’s Argus II System is an implantable neurostimulation device that uses electrical stimulation of the retina to replace the function of the defunct photo-receptors in retinitis pigmentosa patients. Second Sight wrapped up 2016 with an announcement that for the first time in the UK, the publicly-funded NHS system would fund blind patients with retinitis pigmentosa (RP) to receive treatment with Second Sight’s innovative Argus® II Retinal Prosthesis System (Argus II) “bionic eye.” The company most recently announced a rights…

FridayJan 20, 2017 12:31 pm

NetworkNewsBreaks – The Singing Machine Company, Inc. (SMDM) Sees Growing Demand Abroad, Forecasts 100% Increase in International Sales

The Singing Machine Company (OTCQX: SMDM) distributes a full line of increasingly popular consumer-oriented karaoke systems and products that have been featured on Mashable, The Wall Street Journal, Wired, USA Today, and other high-profile publications. The company recently posted its 10th consecutive quarter of YoY growth in sales and earnings, the most recent of which was driven by organic and international growth, new products, and buying trends leading up to the holidays. Second-quarter earnings increased 66% to $0.05 per share on net sales of $28.1 million, an increase of 33% compared to the year ago quarter. Noting strong product demand overseas,…

FridayJan 20, 2017 12:29 pm

NetworkNewsBreaks – MagneGas Corporation (NASDAQ: MNGA) Creates New Revenue Streams in Florida’s Leisure Markets with Commercial Sale of CO2

MagneGas (NASDAQ: MNGA) is a technology company engaged in the renewable resources and environmental solutions industries. The company is known primarily for its patented process that converts various renewables and liquid wastes into MagneGas fuels for use as an alternative to natural gas or for metal cutting. MagneGas recently announced the expansion of its product offering to include the commercial sale of carbon dioxide (CO2), which is primarily used in the food, oil and chemical industries. Recognizing CO2 as a complimentary product offering to its current industrial gas segment and retail infrastructure, the company anticipates that the sale of CO2…

FridayJan 20, 2017 12:27 pm

NetworkNewsBreaks – Ballard Power Systems (NASDAQ: BLDP) Geared to Fight China’s Smog Problem

China’s hazardous levels of air pollution have officials in various cities calling for temporary closures in highways, flights and industrial plants. Meanwhile, Ballard Power Systems (NASDAQ: BLDP) is working with Guangdong Nation Synergy Hydrogen Power Technology Co. Ltd to establish fuel cell stack production in the City of Yunfu in the Guangdong Province. Under an agreement reached in October 2016, Ballard will receive $170 million over five years for a working deal that includes the creation of a joint venture who will manufacture and sell FCvelocity®-9SSL stacks to be used primarily in locally-assembled fuel cell engines to provide propulsion power…

FridayJan 20, 2017 12:23 pm

NetworkNewsBreaks – The Alkaline Water Company Inc. (WTER) Continues Rapid Expansion; Lands 2 More Retail Grocery Chains

The Alkaline Water Company (OTCQB: WTER), developer of the innovative bottled alkaline drinking water Alkaline88, recently announced it will shelve its products in two additional retail grocery chains: Fresh Thyme Farmers Markets and Food Depot. Alkaline88 is now available in more than 20,000 stores throughout the United States. The company is consistently adding news stores to its roster, and in early November said more than 1,800 additional stores in the Southeast are now carrying the Alkaline88 brand – which is expected to increase fiscal 2018 revenue by at least 8%. To learn more visit www.thealkalinewaterco.com About The Alkaline Water Company…

FridayJan 20, 2017 12:22 pm

NetworkNewsBreaks – Advanced Medical Isotope Corp. (ADMD) Targets Cancer, $1B Market with Brachytherapy Devices

Advanced Medical Isotope (OTC: ADMD) (“AMI”) develops cutting-edge brachytherapy devices for therapeutic applications, such as the Y-90 RadioGel™ device. Brachytherapy is the use of radiation to destroy cancerous tumors by placing a radiation source inside or next to the treatment area. AMI is in a booming industry, with the estimated annual sales of brachytherapy products exceeding $1 billion, about half of which are attributed to the United States. In October, the company reported that the first family pet, a cat, was treated for cancer with the company's pet version of the Y-90 RadioGel™ device. The study outcome data will be…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks